Journal article icon

Journal article

Should genetic testing become a standard component of clinical trials in order to advance evidence-based cardiology practice?

Abstract:

Medical therapy currently assumes that all individuals with a given condition should be treated in the same way, guided by empirical evidence from clinical trials. This ignores interindividual differences, which may predict variable therapeutic efficacy or adverse drug reactions. Considerable evidence suggests that genetic makeup determines much of this variability, and major efforts are being made to harness genetics to predict drug responses. Pharmacogenetics can improve the power and infor...

Expand abstract

Actions


Authors


Watkins, H More by this author
Journal:
Dialogues in Cardiovascular Medicine
Volume:
9
Issue:
1
Pages:
36-43
Publication date:
2004
ISSN:
1272-9949
URN:
uuid:197ead76-f0dd-4935-8f59-7eab38a818d7
Source identifiers:
104376
Local pid:
pubs:104376

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP